10/17/2014 - 10:10am

A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.

10/17/2014 - 8:22am

Healthentic, an analytics company that identifies health savings for employers, found the overall vaccination rate of employees was only 10%.

10/15/2014 - 2:52pm

As the Food and Drug Administration begins to explore ways to improve its user-fee program for generic drugs, the Generic Pharmaceutical Association and its members have weighed in with suggestions on how to shore up the law to ensure that it helps bring generics to market faster and provides benefits across the entire healthcare system.

10/15/2014 - 2:52pm

Could the regulatory and scientific logjam that’s keeping copycat biotech medicines off the market and out of the hands of patients and health providers in the United States finally be breaking?

10/15/2014 - 2:52pm

What’s in a name? A lot, apparently, if the name applies to a biosimilar medicine.

10/15/2014 - 1:09pm

The U.S. Supreme Court on Wednesday heard arguments from Teva Pharmaceutical Industries in defense of the patent protecting its $4 billion multiple sclerosis drug Copaxone, according to a Reuters report. 

10/15/2014 - 9:58am

 H. D. Smith was recently announced as a finalist of the 2014 Illinois Family Business of the Year Awards in the Large Family Business of the Year and the Community Service categories.

10/14/2014 - 2:47pm

Impax Labs last week announced the execution of a definitive agreement under which Impax will acquire Tower Holdings. 

10/14/2014 - 2:42pm

U.S. Sen. Bernie Sanders, I-Vt., and U.S. Rep. Elijah Cummings, D-Md., earlier this month launched an investigation into soaring generic drug prices.